Herrera Pérez Guillermo M, Castellano Laura E, Ramírez Valdespino Claudia A
Consejo Nacional de Humanidades, Ciencias y Tecnologías (CONAHCYT), Centro de Investigación en Materiales Avanzados, S. C. (CIMAV), Miguel de Cervantes #120, Complejo Industrial Chihuahua, Chihuahua 31136, Chih., Mexico.
División de Ciencias e Ingenierías Campus León, Universidad de Guanajuato, Loma del Bosque #103, Lomas del Campestre, León de los Aldama 37150, Gto., Mexico.
J Fungi (Basel). 2024 Jun 22;10(7):443. doi: 10.3390/jof10070443.
Nanocompounds are widely used in many fields such as environmental, medicine, or agriculture. Nowadays, these nanocompounds are mainly synthesized by chemical methods, causing environmental pollution and potential health problems. Thus, microorganisms have been investigated as potential nanoparticle green biosynthesizers. The main research is focused on the synthesis of nanoparticles (NPs) using algae, yeast, bacteria, and fungi. Among them, fungi have been the most used, due to their simple and effective mycosynthesis. Fungi as well as other organisms involved in green synthesis of NPs use their secondary metabolites (SMs) to mediate and catalyze the reactions to produce metal nanoparticles (MNPs) as well as being able to act as capping agents producing different physicochemical characteristics and biological activities in the MNPs. Among the various fungi used for mycosynthesis are species, which mediate the production of Ag, Cu, CuO, Zn, ZnO, and other MNPs. Here, we review the main SMs from that have been reported or suggested to contribute to synthesize or act as capping agents and their applications, as well as present the main challenges faced by this type of synthesis.
纳米化合物广泛应用于环境、医学或农业等许多领域。如今,这些纳米化合物主要通过化学方法合成,会造成环境污染和潜在的健康问题。因此,微生物已被作为潜在的纳米颗粒绿色生物合成剂进行研究。主要研究集中在利用藻类、酵母、细菌和真菌合成纳米颗粒(NPs)。其中,真菌的使用最为广泛,因为其真菌合成简单有效。真菌以及参与纳米颗粒绿色合成的其他生物体利用其次级代谢产物(SMs)来介导和催化反应,以生产金属纳米颗粒(MNPs),并且能够作为封端剂,赋予MNPs不同的物理化学特性和生物活性。用于真菌合成的各种真菌中,有一些物种介导了银、铜、氧化铜、锌、氧化锌和其他MNPs的生产。在此,我们综述了已报道或被认为有助于合成或作为封端剂的来自某些真菌的主要SMs及其应用,以及这类合成面临的主要挑战。